A Nomogram for Predicting Overall Survival in Patients with Ewing Sarcoma: a SEER-based Study

Overview

Journal BMC Musculoskelet Disord

Publisher Biomed Central

Specialties Orthopedics
Physiology

Date 2020 Nov 13

PMID 33183244

Citations 11

Authors

Zhenggang Zhou

Jinyu Wang

Liming Fang

Jianlin Ma

Mingbo Guo

Affiliations

Soon will be listed here.

Abstract

Background: Ewing sarcoma, the second most frequent bone tumor in children and adolescents, is often presented with localized disease or metastatic-related symptoms. In this study, we aim to construct and validate a nomogram for patients with Ewing sarcoma to predict the 3- and 5-year overall survival (OS) based on the Surveillance, Epidemiology, and End Results (SEER) database.

Methods: Demographic and clinic pathological characteristics of patients with Ewing sarcoma diagnosed between 2010 and 2015 were extracted from SEER database. Univariate and multivariate Cox analyses were carried out to identify the independent characteristics. The independent factors were further included into the construction of a nomogram. Finally, c-index and calibration curves were used to validate the nomogram.

Results: A total of 578 patients were enrolled into our analysis. The results of univariate Cox analysis showed that age, 7th AJCC stage, 7th AJCC T stage, 7th AJCC N stage, 7th AJCC M stage, metastatic status to lung, liver and bone were significant factors. Multivariate Cox analysis was performed and it confirmed age, N stage and bone metastasis as independent variables. Next, a nomogram was constructed using these independent variables in prediction to the 3- and 5-year OS. Furthermore, favorable results with c-indexes (0.757 in training set and 0.697 in validation set) and calibration curves closer to ideal curves indicated the accurate predictive ability of this nomogram.

Conclusions: The individualized nomogram demonstrated a good ability in prognostic prediction for patients with Ewing sarcoma.

Citing Articles

Prognostic Modeling for Bone Sarcomas Based on a Large Prospective Cohort From a Tertiary Care Cancer Center in India.

Bajpai J, Sarkar L, Rath S, Pawar A, Chandrashekharan A, Panda G JCO Glob Oncol. 2025; 11:e2400142.

PMID: 39913876 PMC: 11892611. DOI: 10.1200/GO.24.00142.

Development and validation of a machine learning-based model to predict postoperative overall survival in patients with soft tissue sarcoma: a retrospective cohort study.

Liu X, Yuan J, Wang X, Yu S Am J Cancer Res. 2024; 14(10):4731-4746.

PMID: 39553229 PMC: 11560808. DOI: 10.62347/ZQVY3877.

Incidence trends, overall survival, and metastasis prediction using multiple machine learning and deep learning techniques in pediatric and adolescent population with osteosarcoma and Ewing's sarcoma: nomogram and webpage.

Zhou C, Li H, Zeng H, Wang P Clin Transl Oncol. 2024; .

PMID: 39333451 DOI: 10.1007/s12094-024-03717-9.

Prognostic factors and overall survival in pelvic Ewing's sarcoma and chordoma: A comparative SEER database analysis.

Tang W, Li R, Lai X, Yu X, He R Heliyon. 2024; 10(17):e37013.

PMID: 39286090 PMC: 11402751. DOI: 10.1016/j.heliyon.2024.e37013.

The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population-based retrospective cohort study.

Huang C, Yu Q, Ding Z, Zhou Z, Shi X Cancer Med. 2022; 12(5):6244-6259.

PMID: 36271609 PMC: 10028057. DOI: 10.1002/cam4.5379.

References

Bosma S, Ayu O, Fiocco M, Gelderblom H, Dijkstra P . Prognostic factors for survival in Ewing sarcoma: A systematic review. Surg Oncol. 2018; 27(4):603-610. DOI: 10.1016/j.suronc.2018.07.016. View

Chen D, Chen G, Jiang W, Fu M, Liu W, Sui J . Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer. JAMA Surg. 2019; 154(3):e185249. PMC: 6439641. DOI: 10.1001/jamasurg.2018.5249. View

Ren Y, Zhang Z, Shang L, You X . Surgical Resection of Primary Ewing's Sarcoma of Bone Improves Overall Survival in Patients Presenting with Metastasis. Med Sci Monit. 2019; 25:1254-1262. PMC: 6387471. DOI: 10.12659/MSM.913338. View

Iasonos A, Schrag D, Raj G, Panageas K . How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008; 26(8):1364-70. DOI: 10.1200/JCO.2007.12.9791. View

Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A . Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan. BMC Musculoskelet Disord. 2018; 19(1):297. PMC: 6098838. DOI: 10.1186/s12891-018-2217-1. View

Seitz G, Urla C, Sparber-Sauer M, Schuck A, Vokuhl C, Blank B . Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials. Pediatr Blood Cancer. 2018; 66(3):e27537. DOI: 10.1002/pbc.27537. View

Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z . Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013; 31(9):1188-95. DOI: 10.1200/JCO.2012.41.5984. View

Adamkova Krakorova D, Kubackova K, Dusek L, Tomas T, Janicek P, Tucek S . Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management. Pathol Oncol Res. 2017; 24(3):623-630. DOI: 10.1007/s12253-017-0291-6. View

Ginsberg J, Goodman P, Leisenring W, Ness K, Meyers P, Wolden S . Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst. 2010; 102(16):1272-83. PMC: 2948841. DOI: 10.1093/jnci/djq278. View

10.

Liu H, Wang J, Zhang D, Lan S, Chen Q . Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients. Med Sci Monit. 2018; 24:9370-9375. PMC: 6320658. DOI: 10.12659/MSM.911882. View

11.

Chen J, Jiang Q, Zhang Y, Yu Y, Zheng Y, Chen J . Clinical Features and Long-Term Outcome of Primary Intracranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: 14 Cases From a Single Institution. World Neurosurg. 2018; 122:e1606-e1614. DOI: 10.1016/j.wneu.2018.11.151. View

12.

Grier H, Krailo M, Tarbell N, Link M, Fryer C, Pritchard D . Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003; 348(8):694-701. DOI: 10.1056/NEJMoa020890. View

13.

Chen L, Macarulla T, Blanc J, Mirakhur B, de Jong F, Belanger B . Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer. Cancers (Basel). 2019; 11(8). PMC: 6721419. DOI: 10.3390/cancers11081068. View

14.

Grunewald T, Cidre-Aranaz F, Surdez D, Tomazou E, de Alava E, Kovar H . Ewing sarcoma. Nat Rev Dis Primers. 2018; 4(1):5. DOI: 10.1038/s41572-018-0003-x. View

15.

Balamuth N, Womer R . Ewing's sarcoma. Lancet Oncol. 2010; 11(2):184-92. DOI: 10.1016/S1470-2045(09)70286-4. View

16.

Wang S, Yang L, Ci B, Maclean M, Gerber D, Xiao G . Development and Validation of a Nomogram Prognostic Model for SCLC Patients. J Thorac Oncol. 2018; 13(9):1338-1348. PMC: 7678404. DOI: 10.1016/j.jtho.2018.05.037. View

17.

Gaspar N, Hawkins D, Dirksen U, Lewis I, Ferrari S, Le Deley M . Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. J Clin Oncol. 2015; 33(27):3036-46. DOI: 10.1200/JCO.2014.59.5256. View

18.

Friedman D, Chastain K, Chou J, Moskowitz C, Adsuar R, Wexler L . Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience. Pediatr Blood Cancer. 2017; 64(11). DOI: 10.1002/pbc.26562. View